ALSO READAlembic Pharmaceuticals receives ANDA approval for Itraconazole Capsules Alembic Pharmaceuticals receives ANDA approval for Fluoxetine Hydrochloride Tablets Ajanta Pharma receives final approval for Duloxetine Hydrochloride Delayed Release Capsules Alembic Pharmaceuticals gets ANDA approval for Telmisartan and Amlodipine Tablets Alembic Pharmaceuticals gets ANDA approval for Zolmitriptan Orally Disintegrating Tablets
From USFDAAlembic Pharmaceuticals announced that the Company has received approval from the US Food & Drug Administration for its Abbreviated New Drug Application for Fenofibric Acid Delayed-Release Capsules, 45 mg and 135 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Trilipix Delayed Release Capsules, 45 mg and 135 mg of Abbvie Inc.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)